0455.HK Tiesioginiai signalai | Didinkite pelną su Getagraph.com

Live Chart Being Loaded With Signals

Commentary (29 bal. 2024 @ 04:48):

Stats
Šios dienos apimtis	10 000.00
Vidutinė apimtis	395 016
Rinkos kapitalizacija	569.76M
EPS	HKD0 ( 2023-08-28 )
Last Dividend	HKD0.00260 ( 2023-06-29 )
Next Dividend	HKD0 ( N/A )
P/E	-26.50
ATR14	HKD0 (0.00%)

Tianda Pharmaceuticals Koreliacija

10 Labiausiai teigiamai susiję koreliacijos

10 Labiausiai neigiamai susiję koreliacijos

Ar žinojote?

Koreliacija yra statistinis rodiklis, aprašantis ryšį tarp dviejų kintamųjų. Jis svyruoja nuo -1 iki 1, kur -1 reiškia tobulo neigiamo ryšio koreliaciją (padidėjus vienam kintamajam, sumažėja kitas), 1 reiškia tobulo teigiamo ryšio koreliaciją (padidėjus vienam kintamajam, padidėja ir kitas), o 0 reiškia jokios koreliacijos (tarp kintamųjų nėra jokio ryšio).

Koreliacija gali būti naudojama analizuojant bet kurių dviejų kintamųjų ryšį, ne tik akcijų. Jis dažnai naudojamas finansų, ekonomikos, psichologijos ir kitose srityse.

Tianda Pharmaceuticals Finansinės ataskaitos

Annual	2023
Pajamos:	HKD532.09M
Bruto pelnas:	HKD255.53M (48.02 %)
EPS:	HKD-0.0112

FY	2023
Pajamos:	HKD532.09M
Bruto pelnas:	HKD255.53M (48.02 %)
EPS:	HKD-0.0112

FY	2022
Pajamos:	HKD546.69M
Bruto pelnas:	HKD251.52M (46.01 %)
EPS:	HKD-0.0254

FY	2022
Pajamos:	HKD509.96M
Bruto pelnas:	HKD241.22M (47.30 %)
EPS:	HKD-0.0101

Financial Reports:

No articles found.

Tianda Pharmaceuticals Dividends

(Q3/22)	(Q4/22)	(Q1/23)	(Q2/23)	(Q3/23)	(Q4/23)	(Q1/24)	(Q2/24)	(Q3/24)	(Q4/24)
HKD0.0112 (N/A)	HKD0 (N/A)	HKD0 (N/A)	HKD0.00260 (N/A)	HKD0 (N/A)	HKD0 (N/A)	HKD0 (N/A)	HKD0 (N/A)	HKD0 (N/A)	HKD0 (N/A)

Tianda Pharmaceuticals Dividend Information - Ex Dividend Junior

Dividend Sustainability Score: 4.25 - low (41.27%) | Divividend Growth Potential Score: 0 - No dividend expected

Very Unsafe

High risk of being cut

Unsafe

Heightened risk of being cut

Borderline

Moderate risk of being cut

Safe

Unlikely to be cut

Very Safe

Very unlikely to be cut

Information

First Dividend	HKD0.00450	2010-07-23
Last Dividend	HKD0.00260	2023-06-29
Next Dividend	HKD0	N/A
Payout Date	0000-00-00
Next Payout Date	N/A
# dividends	14	--
Total Paid Out	HKD0.0530	--
Avg. Dividend % Per Year	0.00%	--
Score	1.23	--
Div. Sustainability Score	4.25
Div.Growth Potential Score	0
Div. Directional Score	1.955	--

Next Divdend (Est)
(2024-05-07)

HKD0.00229 Estimate 3.07 %

Dividend Stability

0.25 Very Poor

Dividend Score

1.23

Pay Frequency

Annually

Yearly Payout

Year	Amount	Yield

Dividend Commentary

The company's low Dividend Sustainability Score (DSS) highlights potential challenges in upholding its current dividend levels. Unfortunately, its low Dividend Growth Potential Score (DGPS) suggests limited prospects for dividend growth. In conclusion, a more vigilant stance is recommended given the company's tentative dividend landscape.

Top 10 dividend Companies for HKSE

Symbol	Title	Last dividend	Frequency	Yearly Dividend
9997.HK	Ex Dividend Knight	2023-05-30	Annually	0.00%
2202.HK	Ex Dividend Junior	2023-07-14	Annually	0.00%
1209.HK	Ex Dividend Knight	2023-09-12	Semi-Annually	0.00%
0288.HK	Ex Dividend Knight	2023-08-28	Semi-Annually	0.00%
3968.HK	Ex Dividend Knight	2023-07-05	Annually	0.00%
1786.HK	Ex Dividend Junior	2023-07-04	Sporadic	0.00%
0822.HK	Ex Dividend Junior	2023-06-05	Annually	0.00%
2362.HK	No Dividend Player	2023-06-01	Annually	0.00%
1349.HK	Ex Dividend Junior	2023-06-05	Annually	0.00%
0393.HK	Ex Dividend Knight	2023-09-14	Semi-Annually	0.00%

Dividend Sustainability Score (DSS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
netProfitMarginTTM	-0.0454	1.500	-0.908	-1.362	[0 - 0.5]
returnOnAssetsTTM	-0.0263	1.200	-0.878	-1.053	[0 - 0.3]
returnOnEquityTTM	-0.0405	1.500	-1.561	-2.34	[0.1 - 1]
payoutRatioTTM	0	-1.000	0	0	[0 - 1]
currentRatioTTM	1.099	0.800	9.51	7.61	[1 - 3]
quickRatioTTM	0.854	0.800	9.68	7.75	[0.8 - 2.5]
cashRatioTTM	0.518	1.500	8.23	10.00	[0.2 - 2]
debtRatioTTM	0.120	-1.500	7.99	-10.00	[0 - 0.6]
interestCoverageTTM	-5.45	1.000	-3.13	-3.13	[3 - 30]
operatingCashFlowPerShareTTM	-0.0241	2.00	-0.00802	-0.0160	[0 - 30]
freeCashFlowPerShareTTM	-0.0424	2.00	-0.0212	-0.0424	[0 - 20]
debtEquityRatioTTM	0.187	-1.500	9.25	-10.00	[0 - 2.5]
grossProfitMarginTTM	0.480	1.000	5.33	5.33	[0.2 - 0.8]
operatingProfitMarginTTM	-0.0545	1.000	-3.09	-3.09	[0.1 - 0.6]
cashFlowToDebtRatioTTM	-0.468	1.000	-3.71	-3.71	[0.2 - 2]
assetTurnoverTTM	0.580	0.800	9.47	7.57	[0.5 - 2]
Total Score				4.25

Dividend Growth Score (DGS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
peRatioTTM	-23.59	1.000	-2.48	0	[1 - 100]
returnOnEquityTTM	-0.0405	2.50	-1.003	-2.34	[0.1 - 1.5]
freeCashFlowPerShareTTM	-0.0424	2.00	-0.0141	-0.0424	[0 - 30]
dividendYielPercentageTTM	0.981	1.500	10.00	0	[0 - 0.4]
operatingCashFlowPerShareTTM	-0.0241	2.00	-0.00802	-0.0160	[0 - 30]
payoutRatioTTM	0	1.500	0	0	[0 - 1]
pegRatioTTM	0.156	1.500	-2.30	0	[0.5 - 2]
operatingCashFlowSalesRatioTTM	-0.0972	1.000	-4.93	0	[0.1 - 0.5]
Total Score				-0.341

Tianda Pharmaceuticals

Tianda Pharmaceuticals Limited, an investment holding company, engages in the research and development, production, and sale of pharmaceutical, biotechnology, and healthcare products in Mainland China, Hong Kong, and Australia. Its product range includes Chinese medicines, chemical drugs, biological and health products, and medical appliances covering the area of cardio-cerebrovascular, pediatric, anti-flu and respiratory, anti-infection, detoxification, urological agents, and others. The company offers its health products under the Herb Valley and Tuokang brands. It also engages in the sale and wholesale of Chinese herbal medicines, traditional Chinese medicine decoction pieces and Chinese medicines; provision of Chinese medical services; and trading of agricultural by-products. The company was formerly known as Tianda Holdings Limited and changed its name to Tianda Pharmaceuticals Limited in September 2012. The company was incorporated in 1992 and is headquartered in Central, Hong Kong. Tianda Pharmaceuticals Limited is a subsidiary of Tianda Group Limited.